Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by bealerton Jun 29, 2020 10:03pm
192 Views
Post# 31205913

RE:RE:Results

RE:RE:ResultsI would estimate up to one year with cash on hand if they closely control the spending and don't give themselves any bonuses.

Another PP and we'll have over 300 Million shares o/s.  If we don't start to get some serious revenue  by one year, that will be the ultimate test of survival, and if we don't get some good mileage out of the coming results from SGLT as a second possible source of future revenue, then I wouldn't want to guess how serious it would be by that time.

Play time has to end soon and some serious numbers have to come out within months or we will lose yet further investor confidence.

These remarks are NOT being negative, but rather realistic from how I feel personally about the whole situation.

Yes, it would be great to offer encouragement to mgmt. but give us some reasons to do so by disclosing whal the h*ell is happening with the numbers and results of the latest 1067 trials, plus whatever else.  

Instead of spending $42,000.00 these past 3 months and $80,000.00 on last year's 3 months public relations budgets, spend a little of that wasted money on telling the truth to shareholders.

BeAlert and GLTA. Looks like we can keep the doors open for a while yet!!
<< Previous
Bullboard Posts
Next >>